Helicobacter pylori (H. pylori) colonizes the stomach of more than half of the world's population, mainly in developing countries. 1, 2 In fact, the burden of H. pylori infection is mostly borne by developing countries and specific high-risk groups in poor communities. 3 This infection is associated with chronic gastritis, peptic ulcer disease and mucosa-associated lymphoid tissue (MALT) lymphoma in children and adults, and with development of gastric cancer, which occurs typically in adulthood. 4 Although the incidence and mortality rates for gastric cancer have been slowly decreasing in many countries over the last five decades, it is still the fifth most common cause of cancer-related deaths, and more than 70% of gastric cancer cases occur in developing countries. 5 Thus, gastric cancer will still remain an important healthcare problem over the coming decades, particularly in poor communities.
breath test and stool antigen test), detection of serum-specific anti-H. pylori antibodies is the only one available in Brazil, and this is limited to a few laboratories in big cities.
Anti-H. pylori immunoglobulin G (IgG) antibody detection by means of the enzyme-linked immunosorbent assay (ELISA)
is the third-best method for noninvasive screening for H. pylori infection. 8 It might be suggested as the first method, in high-prevalence areas, if the urea breath test and stool antigen test are not available. 9 Furthermore, serological tests are considered to be the most efficient diagnostic method under certain clinical situations in which local changes in the stomach may affect the results from other tests (i.e. in cases of gastrointestinal bleeding, atrophic gastritis, gastric MALT lymphoma and gastric carcinoma), or when antibiotics or proton pump inhibitors are used. 8 ELISA tests developed using H. pylori antigens from local samples usually present better accuracy than that of commercial tests based on non-local H. pylori antigen. One of the main criticisms of commercial tests is that they are widely used in any population (including in developing countries). Therefore, development of a local test has been encouraged. [10] [11] [12] [13] [14] [15] [16] [17] Hence, an easily performed, low-cost, locally developed and validated noninvasive test, for widespread use, might be recommendable for screening for H. pylori infection. In particular, use of such tests might potentially reduce the need to perform invasive tests, in a test-and-treat strategy.
OBJECTIVE
The aims of this study were to develop and validate an ELISAbased serological test using whole-cell antigen of cultured H. pylori from gastric biopsies on Brazilian patients, in order to detect anti-H. pylori IgG antibodies in children and adults. 
METHODS

Design and setting
Gastric biopsy samples and strain isolation
We examined a series of preserved frozen cultures (-80 °C) that had been isolated from gastric biopsy samples from 29 children and adolescents and 27 adult patients who were attended at the endoscopy units of two public hospitals: Hospital São Paulo, a university hospital, and Hospital Infantil Cândido Fontoura, a secondary-level children's hospital, which are both in the city of São Paulo, Brazil. Antral gastric biopsies were processed and cultured in brain-heart infusion (BHI) agar (BHI Agar, BD Difco, Becton-Dickinson, NJ, USA), on plates that were incubated for 10-14 days under microaerophilic conditions, as previously described. 18
Virulence gene detection by means of conventional PCR
Samples of bacteria were harvested from a three-day-old culture and were suspended in 1 ml of distilled water for deoxyribonucleic acid (DNA) extraction (Wizard genomic DNA purification kit, Promega), in accordance with the manufacturer's instructions. For H. pylori DNA confirmation, a PCR specific for the H. pylori UreA and B genes was used. 19 PCR amplification of the VacA signal sequence and midregion, and of the gene CagA, was performed as previously described. 20, 21 Negative and positive controls were included in all reactions. 
Antigen preparation
Whole-cell antigen from a sonicated pool (Ultrasonic Disruptor QR500W, Ultronique, Brazil) of 56 strains was obtained as previously described. 22 Antigen preparation was adjusted to a protein concentration of 1 mg/ml, 23 and aliquots of 100 µl were stored at -20 °C until used.
ELISA standardization
Detection of anti-H. pylori IgG antibodies was, firstly, tested on 10 H. pylori-positive patients (five adults and five children) and 10 H. pylori-negative patients (five adults and five children), who formed positive and negative serum controls, respectively.
Their diagnoses were based on invasive methods: the gold standard for positive diagnoses was a positive culture and/or positive histological test and a positive rapid urease test; and, for negative diagnoses, all three tests needed to be negative.
Standardization was performed as previously described by Camorlinga-Ponce et al. 23 For each assay, the optimal antigen concentration and working serum dilution were determined based on checkerboard titrations. ELISA plates were prepared as previously described. 22 Polyclonal and monoclonal antibodies were used to evaluate the best detection test. Polyclonal antibodies comprise collections of antibodies from different B cells that recognize multiple epitopes on the same antigen. For this reason, they provide greater sensitivity, even for detecting proteins that are present in low quantities in a sample. In contrast, monoclonal antibodies comprise antibodies from a single antibody-producing B cell. Thus, they bind with a single epitope. This is highly specific, with only a small risk of cross-reactivity, and it can provide better results in assays requiring quantification of the protein levels.
For Analysis on the checkerboard titration for polyclonal antibodies showed that the following were the optimal concentrations: for antigen preparation, 1:500 (2 µg/ml); for working serum dilution, 1:400;
and for peroxidase-conjugated anti-human antibodies, 1:60,000.
For monoclonal antibodies, the following were the optimal concentrations: for antigen preparation, 1:300 (3.3 µg/ ml); for working serum dilution, 1:400; and for alkaline phosphatase-conjugated anti-human antibodies, 1:25,000. The best reading time for monoclonal antibodies was 25 minutes. ELISA tests were run for four consecutive days to evaluate interoperability and reproducibility.
Antigen specificity
The cross-reactivity of the in-house ELISA serological tests for formed through competitive inhibition assays, as previously described. 24 No positive reactions were observed.
Determination of cutoff
The optical density (OD) cutoffs for the monoclonal and polyclonal tests were determined based on the serum antibody responses of 100 samples (50 adults and 50 children and adolescents) from H. pylori-negative uninfected patients, based on the gold standard. Thus, a pool of these 100 serum samples was used as the negative serum control. The threshold for positivity was defined as the mean value plus three standard deviations of the optical density, as previously described. 23 These values were compared with the values from a collection of 82 serum samples (33 
RESULTS
Patients
Between 
Validation of the ELISA serological assay
Analysis on the overall seropositive results (EU > 1.0) from the monoclonal test presented little difference in values, compared with the polyclonal test, but the sensitivity and negative predictive values were slightly higher with monoclonal antibodies.
When age was considered, the monoclonal test presented a better result for sensitivity among adults, but specificity was better among children and adolescents. In contrast, the polyclonal test presented a better result for sensitivity among children and adolescents. The accuracy was slightly better among children and adolescents in the monoclonal test and among adults in the polyclonal test ( Table 1) .
DISCUSSION
In this study, ELISA-based serological tests to detect monoclonal and polyclonal IgG antibodies using H. pylori whole-cell antigen from strains isolated in our community were developed, standardized, validated and evaluated. The sensitivity and specificity of the in-house serological tests for both polyclonal antibodies (78.9% and 90.6%) and monoclonal antibodies (84.3% and 88.6%) were similar to those found by Camorlinga-Ponce et al. 23 (85% and 89.7%). The in-house ELISA serological test that we developed did not present any cross-reactivity to heterologous bacterial species.
The sample size was appropriate, given that both the sensitivity and the specificity presented narrow 95% confidence intervals.
Selectivity in relation to gastroduodenal diseases can influence the sensitivity and specificity results. A study conducted by Aziz et al. 17 found higher OD values and this may have occurred because their study was based on peptic ulcer disease patients. In the present study, adults, children and adolescents were evaluated together, and the OD results presented little variation. However, other studies conducted on Brazilian populations have shown that age had an influence on the sensitivity and specificity of commercial tests. [26] [27] Both commercial and in-house serological tests have presented large ranges of sensitivity and specificity results. Leal et al. 14 The accuracy of serological tests can also be affected by the choice of antigen that is used to prepare the in-house ELISA assay.
In some studies, H. pylori genetic heterogeneity was taken into consideration in choosing the whole-cell lysate (with sonication). 28, 29 In our study, the strains used in the antigenic pool were verified genetically, to obtain better representativeness, including the CagA and VacA strains (alleles s1m1, s1m2, s2m1 and s2m2). The genotypic distribution in our study was similar to what has been found in other studies in Brazil. 30, 31 The diagnostic accuracy of a serological test is enhanced when the antigen pool is prepared based on multiple strains. Widmer et al. 32 evaluated the performance of three antigenic preparations and observed that the results were superior when an enzyme immunoassay prepared with a pool of native antigens was used (sensitivity:
90-100%; specificity: 90-97%), rather than with recombinant antigen (sensitivity: 59-78%; specificity: 41-100%). Serological tests based on whole-cell antigen or whole-cell antigen lysate have also shown good performance among both children and adult patients. 11, 23, 24, 33 Despite the simplicity of ELISA serological tests, attention during their development is needed. In particular, the optimal antigen concentration, serum sample dilution and antibody conjugation need to be determined. These parameters should be optimized and adjusted to local conditions, to the population studied and to the method developed. 17, 34 The optimal concentrations in the present study were determined by means of the checkerboard titration method. It is very important to make these determina- 
